201 related articles for article (PubMed ID: 12431867)
1. TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients.
Pea F; Bertolissi M; Di Silvestre A; Poz D; Giordano F; Furlanut M
Int J Antimicrob Agents; 2002 Nov; 20(5):326-32. PubMed ID: 12431867
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
[TBL] [Abstract][Full Text] [Related]
3. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Pea F; Porreca L; Baraldo M; Furlanut M
J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
[TBL] [Abstract][Full Text] [Related]
4. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
5. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
[TBL] [Abstract][Full Text] [Related]
6. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
[TBL] [Abstract][Full Text] [Related]
7. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
Guo T; van Hest RM; Zwep LB; Roggeveen LF; Fleuren LM; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG; van Hasselt JGC
Pharm Res; 2020 Aug; 37(9):171. PubMed ID: 32830297
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
[TBL] [Abstract][Full Text] [Related]
9. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
10. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
Rao Z; Guo SM; Wei YM
Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
Huang M; Wu H; Zhou J; Xu M; Zhou S
Arch Iran Med; 2018 Aug; 21(8):349-355. PubMed ID: 30113856
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study.
Bakke V; Sporsem H; Von der Lippe E; Nordøy I; Lao Y; Nyrerød HC; Sandvik L; Hårvig KR; Bugge JF; Helset E
Acta Anaesthesiol Scand; 2017 Jul; 61(6):627-635. PubMed ID: 28444760
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
[TBL] [Abstract][Full Text] [Related]
15. Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis.
Yu Z; Liu J; Yu H; Zhou L; Zhao Y; Zhong L; Zhu J; Liang G; Yang Y; Zheng Y; Yu L; Han G
Int J Antimicrob Agents; 2023 Jun; 61(6):106812. PubMed ID: 37037321
[TBL] [Abstract][Full Text] [Related]
16. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
[TBL] [Abstract][Full Text] [Related]
17. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.
Carreno JJ; Lomaestro B; Tietjan J; Lodise TP
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289024
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.
Iwamoto T; Kagawa Y; Kojima M
Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304
[TBL] [Abstract][Full Text] [Related]
19. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
Ye ZK; Tang HL; Zhai SD
PLoS One; 2013; 8(10):e77169. PubMed ID: 24204764
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
Cao G; Liang X; Zhang J; Zhou Y; Wu J; Zhang Y; Chen Y; Huang J; Liu X; Yu J
J Clin Pharm Ther; 2015 Dec; 40(6):640-4. PubMed ID: 26383121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
